The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concordance between comprehensive cancer genome profiling in plasma and matched tumor specimens.
 
Roopika Menon
Employment - Neoantigenics
Leadership - Neoantigenics
Stock and Other Ownership Interests - Neoantigenics
 
Judith N Müller
Employment - Neoantigenics
 
Markus Falk
No Relationships to Disclose
 
Sotirios Lakis
Employment - Neoantigenics
Consulting or Advisory Role - BioNTech Diagnostics
 
Erika Mariotti
Employment - Philips Healthcare (I); Siemens Healthcare Diagnostics
Stock and Other Ownership Interests - Philips Healthcare
Research Funding - Philips Research (I)
Patents, Royalties, Other Intellectual Property - Philips Healthcare (I)
Travel, Accommodations, Expenses - Philips Healthcare (I); Siemens Healthcare Diagnostics
 
Frauke Leenders
Employment - NEO New Oncology
Stock and Other Ownership Interests - NEO New Oncology
 
Miriam Bertrand
Employment - Neoantigenics
 
Nicole Neemann
Employment - Neoantigenics
 
Maria Netchaeva
No Relationships to Disclose
 
Lukas C. Heukamp
Employment - NEO New Oncology
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche Pharma AG
 
Christian Gloeckner
Employment - New Oncology
Leadership - New Oncology
Stock and Other Ownership Interests - New Oncology
Patents, Royalties, Other Intellectual Property - Illumina
 
Markus Tiemann
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst)
 
Johannes Heuckmann
Employment - Neoantigenics
Leadership - Neoantigenics
Stock and Other Ownership Interests - NEO New Oncology
Patents, Royalties, Other Intellectual Property - NEO New Oncology (Inst)
Travel, Accommodations, Expenses - Novartis
 
Frank Griesinger
No Relationships to Disclose